The potential function of microRNAs as biomarkers and therapeutic targets in multiple myeloma

Multiple myeloma (MM), accounting for ~1% of all types of human cancer and 13% of all hematological malignancies, is characterized by the malignant proliferation of monoclonal plasma cells (PCs) in the bone marrow. MM leads to end stage organ impairment, including bone lesions, renal dysfunction, hy...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Bingying, Ju, Shaoqing, Chu, Haidan, Shen, Xianjuan, Zhang, Yan, Luo, Xi, Cong, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920744/
https://www.ncbi.nlm.nih.gov/pubmed/29731841
http://dx.doi.org/10.3892/ol.2018.8157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920744/
https://www.ncbi.nlm.nih.gov/pubmed/29731841
http://dx.doi.org/10.3892/ol.2018.8157

Ejemplares similares